Skip to main content

Peer Review reports

From: Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer

Original Submission
11 Feb 2012 Submitted Original manuscript
19 Apr 2012 Reviewed Reviewer Report - Motoki Miyazawa
31 May 2012 Reviewed Reviewer Report - Alfredo Carrato
Resubmission - Version 2
Submitted Manuscript version 2
12 Jul 2012 Author responded Author comments - Friedrich Hubertus Schmitz-Winnenthal
Resubmission - Version 3
12 Jul 2012 Submitted Manuscript version 3
Publishing
17 Jul 2012 Editorially accepted
20 Aug 2012 Article published 10.1186/1471-2407-12-361

You can find further information about peer review here.

Back to article page